T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Manitowoc
MTW
$727M
| $24M | ﹤0.01% |
1,003,435
+18,913
| +2% | +$390K |
|
1077
Essent Group
ESNT
$6.14B
| $24M | ﹤0.01% |
740,146
+52,373
| +8% | +$1.54M |
|
|
XTLY
1078
DELISTED
Xactly Corporation
XTLY
| $23.8M | ﹤0.01% |
2,163,204
+312,020
| +17% | +$4.07M |
|
1079
Coherus Oncology
CHRS
$181M
| $23.8M | ﹤0.01% |
844,832
+13,510
| +2% | +$378K |
|
|
LM
1080
DELISTED
Legg Mason, Inc.
LM
| $23.7M | ﹤0.01% |
793,803
-272,046
| -26% | -$8.55M |
|
|
GTS
1081
DELISTED
Triple-S Management Corporation
GTS
| $23.7M | ﹤0.01% |
1,202,108
-7,463
| -0.6% | -$155K |
|
1082
Oil-Dri
ODC
$1.27B
| $23.6M | ﹤0.01% |
1,232,660
| – | – |
|
1083
BorgWarner
BWA
$14B
| $23.5M | ﹤0.01% |
675,731
-3,596,012
| -84% | -$116M |
|
1084
Golub Capital BDC
GBDC
$3.48B
| $23.5M | ﹤0.01% |
1,302,163
+60,096
| +5% | +$1.08M |
|
1085
The Ensign Group
ENSG
$10.6B
| $23.3M | ﹤0.01% |
1,121,868
-15,971
| -1% | -$311K |
|
1086
Oneok
OKE
$58.3B
| $23.3M | ﹤0.01% |
405,610
-3,110
| -0.8% | -$163K |
|
1087
Advance Auto Parts
AAP
$3.23B
| $23.2M | ﹤0.01% |
137,205
-2,300
| -2% | -$362K |
|
1088
Ardelyx
ARDX
$1.01B
| $23M | ﹤0.01% |
1,617,321
-220,272
| -12% | -$3.13M |
|
1089
Perrigo
PRGO
$1.76B
| $22.9M | ﹤0.01% |
275,515
+6,795
| +3% | +$589K |
|
|
CSFL
1090
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $22.8M | ﹤0.01% |
907,329
+745,300
| +460% | +$15.8M |
|
|
WBMD
1091
DELISTED
WebMD Health Corp.
WBMD
| $22.8M | ﹤0.01% |
460,620
-17,030
| -4% | -$880K |
|
|
PRXL
1092
DELISTED
Parexel International Corp
PRXL
| $22.8M | ﹤0.01% |
347,205
-10,155
| -3% | -$637K |
|
|
LLL
1093
DELISTED
L3 Technologies, Inc.
LLL
| $22.8M | ﹤0.01% |
149,788
+344
| +0.2% | +$51.8K |
|
1094
Charles River Laboratories
CRL
$13.4B
| $22.6M | ﹤0.01% |
296,607
-5,677
| -2% | -$431K |
|
1095
Dover
DOV
$28B
| $22.5M | ﹤0.01% |
372,173
-10,851
| -3% | -$627K |
|
1096
Coca-Cola Consolidated
COKE
$12.6B
| $22.5M | ﹤0.01% |
1,258,570
+800
| +0.1% | +$12.5K |
|
|
ARRY
1097
DELISTED
Array Biopharma Inc
ARRY
| $22.5M | ﹤0.01% |
2,555,744
+2,410,572
| +1,660% | +$17.7M |
|
1098
CMS Energy
CMS
$22B
| $22.4M | ﹤0.01% |
537,581
+4,400
| +0.8% | +$180K |
|
|
SASR
1099
DELISTED
Sandy Spring Bancorp Inc
SASR
| $22.4M | ﹤0.01% |
559,290
-656,330
| -54% | -$22.7M |
|
1100
Orion
OEC
$364M
| $22.2M | ﹤0.01% |
1,178,481
-11,853
| -1% | -$226K |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.